Comparative Effectiveness of Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: A Propensity-Matched Cohort Analysis

被引：0
|
作者：
Kochhar, Gursimran S. [1 ]
Khataniar, Himsikhar [1 ]
Hashash, Jana G. [2 ]
Farraye, Francis A. [2 ]
Desai, Aakash [3 ]
机构：
[1] Allegheny Gen Hosp, Pittsburgh, PA USA
[2] Mayo Clin, Jacksonville, FL USA
[3] Mayo Clin, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001033780.31178.74
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1103
引用
收藏
页码：S780 / S781
页数：2
相关论文
共 50 条
  • [21] Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitis
    Yokomizo, Lauren
    Limketkai, Berkeley
    Park, K. T.
    BMJ OPEN GASTROENTEROLOGY, 2016, 3 (01):
  • [22] Risk of Tofacitinib-Related Adverse Events in Patients With Ulcerative Colitis: A Nationwide Propensity-Matched Cohort Study
    Kochhar, Gursimran S.
    Desai, Aakash
    Cross, Raymond
    Farraye, Francis A.
    Hanauer, Stephen B.
    Dulai, Parambir S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S620 - S621
  • [23] Real-World Effectiveness and Onset of Action of Vedolizumab as a First-Line Biologic in Biologic-Naïve Patients With Ulcerative Colitis
    Anyanwu, Precious A.
    Van Anglen, Lucinda J.
    Chou, Chiahung
    Sanchirico, Marie
    Ritter, Timothy E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S876 - S877
  • [24] Carperitide versus nitroglycerin as a first-line therapy in patients with acute heart failure: a propensity-matched comparison
    Iwakami, N.
    Nagai, T.
    Sugano, Y.
    Shibata, T.
    Asaumi, Y.
    Noguchi, T.
    Kusano, K.
    Ogawa, H.
    Yasuda, S.
    Anzai, T.
    EUROPEAN HEART JOURNAL, 2015, 36 : 546 - 546
  • [25] Clinical Effectiveness of First-Line Anti-TNF Therapies and Second-Line Anti-TNF Therapy Post-Vedolizumab Discontinuation in Patients With Ulcerative Colitis or Crohn's Disease
    Bressler, Brian
    Yarur, Andres
    Kopylov, Uri
    Bassel, Marielle
    Brett, Neil R.
    Lissoos, Trevor
    Lopez, Claudia
    Natsios, Athanasios
    Saha, Sumit
    Kifnidi, Christina
    Demuth, Dirk
    Patel, Haridarshan
    Mantzaris, Gerassimos J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S373 - S373
  • [26] A real-world comparison of the effectiveness and safety of vedolizumab and anti-TNF therapies in early treatment initiation with first-line biologic therapy in ulcerative colitis: Results from EVOLVE
    Mantzaris, G.
    Bressler, B.
    Kopylov, U.
    Bassel, M.
    Brett, N.
    Colby, C.
    Lopez, C.
    Saha, S.
    Kifnidi, C.
    Agboton, C.
    Adsul, S.
    Demuth, D.
    Luo, M.
    Wang, S.
    Yarur, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S092 - S094
  • [27] A REAL-WORLD COMPARISON OF THE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF THERAPIES IN EARLY TREATMENT INITIATION WITH FIRST-LINE BIOLOGIC THERAPY IN ULCERATIVE COLITIS: RESULTS FROM EVOLVE
    Mantzaris, Gerassimos J.
    Bressler, Brian
    Kopylov, Uri
    Bassel, Marielle
    Brett, Neil R.
    Colby, Chris
    Lopez, Claudia
    Saha, Sumit
    Kifnidi, Christina
    Agboton, Christian
    Adsul, Shashi
    Demuth, Dirk
    Luo, Michelle
    Wang, Song
    Yarur, Andres J.
    GASTROENTEROLOGY, 2020, 158 (06) : S405 - S405
  • [28] Selecting first-line advanced therapy for ulcerative colitis: A clinical application of personalized medicine
    Mukhtar, Mariam S.
    Mosli, Mahmoud H.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2024, 30 (03): : 126 - 137
  • [29] Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis-it depends on how you use the drug
    Con, Danny
    Srinivasan, Ashish
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (01) : 140 - 141
  • [30] Comparative effectiveness and safety of upadacitinib, tofacitinib, and filgotinib in patients with Ulcerative Colitis: analysis of whole and propensity score-matched data
    Bertin, L.
    Scarabello, D.
    Zingone, F.
    Savarino, E., V
    Barberio, B.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1294 - i1295
12345